Colorectal cancer screening
- PMID: 17106920
- PMCID: PMC4087426
- DOI: 10.3748/wjg.v12.i42.6747
Colorectal cancer screening
Abstract
Colorectal cancer is a major public health burden worldwide. There is clear-cut evidence that screening will reduce colorectal cancer mortality and the only contentious issue is which screening tool to use. Most evidence points towards screening with fecal occult blood testing. The immunochemical fecal occult blood tests have a higher sensitivity than the guaiac-based tests. In addition, their automation and haemoglobin quantification allows a threshold for colonoscopy to be selected that can be accommodated within individual health care systems.
References
-
- Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents. Volumes I to VIII. Lyon: IARC Press; 2005. pp. 1–56.
-
- Moreaux J, Catala M. Carcinoma of the colon: long-term survival and prognosis after surgical treatment in a series of 798 patients. World J Surg. 1987;11:804–809. - PubMed
-
- Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum. 1995;38:1286–1295. - PubMed
-
- Wilcox GM, Anderson PB, Colacchio TA. Early invasive carcinoma in colonic polyps. A review of the literature with emphasis on the assessment of the risk of metastasis. Cancer. 1986;57:160–171. - PubMed
-
- Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical